Drug-eluting stents (DES) in the general population are preferred over bare-metal stents (BMS); they even play a role in treatment of the (very) elderly. Recent results indicate superior outcomes of DES in in patients in their eighties and nineties.
Mishra et al. presented results of a retrospective observational analysis of claims data. The authors aimed to compare outcomes between the two types of stent in this very elderly population, using an American nationwide readmission database (2010-2014) to identify patients aged 80 years who had percutaneous coronary intervention (PCI) using DES or BMS based on international classification of disease codes (9th revision [ICD:9-CM]) . Primary endpoints were 30-day readmission, in-hospital mortality, post-procedure complications, and cost of care. A total of 297,378 qualifying subjects were identified (30.7% BMS; 69.3% DES). Significantly less utilisation of DES was observed in nonagenarians vs octogenarians ...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Smartwatch can detect atrial fibrillation with high degree of accuracy Next Article
Less bleeding and fewer hospitalisations with antithrombotic regimen with apixaban without aspirin »
Table of Contents: ACC 2019
Acute and Stable Ischaemic Heart Disease
Arrhythmias and Clinical Electrophysiology
Congenital Heart Disease
Heart Failure and Cardiomyopathies
Pulmonary Arterial Hypertension and Venous Thromboembolism
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.